Proqr Therapeutics Nv earnings were -$53.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest PRQR earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$15.4M, up 46.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PRQR reported annual earnings of -$49.6M, with 71.6% growth. The next PRQR earnings date is Aug 6, 2026.
Proqr Therapeutics Nv Earnings Reports & History FAQ
What were Proqr Therapeutics Nv's earnings last quarter?
Proqr Therapeutics Nv (NASDAQ: PRQR) reported Q1 2026 earnings per share (EPS) of -$0.15, up 36.7% year over year. Total PRQR earnings for the quarter were -$15.38 million. In the same quarter last year, Proqr Therapeutics Nv's earnings per share (EPS) was -$0.11.
The next PRQR earnings date is Aug 6, 2026. Add PRQR to your watchlist to be reminded of Proqr Therapeutics Nv's next earnings date.
Is Proqr Therapeutics Nv profitable or losing money?
As of the last Proqr Therapeutics Nv earnings report, Proqr Therapeutics Nv is currently losing money. Proqr Therapeutics Nv's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$52.29 million, a 59.36% increase year over year.
What was PRQR's earnings growth in the past year?
As of Proqr Therapeutics Nv's earnings date in Q3 2026, Proqr Therapeutics Nv's earnings has grown year over year. PRQR earnings in the past year totalled -$53.52 million.
What are Proqr Therapeutics Nv's earnings expectations?
The current EPS estimate for Proqr Therapeutics Nv's earnings report in Aug 6, 2026 is -$0.14.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.